Jul 15, 2026
1:5
For every 5 shares held, investors received 1. The price per share adjusted from $534.00 to $2670.00.
The split itself did not change the total investment value.
GeneOne Life Science, Inc. (KRX:011000) operates in the Biotechnology industry.
GeneOne Life Science, Inc. company overviewGeneOne Life Science, Inc.'s most recent stock split was on July 15, 2026. It was a 1-for-5 reverse split, so shareholders received 1 share for every 5 they held.
GeneOne Life Science, Inc. (KRX:011000) has split its stock 13 times: a 5-for-1 split on February 6, 2006, a 5-for-1 split on February 15, 2006, a 5-for-1 split on July 12, 2006, a 94-for-87 split on July 8, 2009, a 166-for-155 split on June 30, 2011, a 247-for-227 split on August 29, 2014, a 1-for-5 reverse split on February 12, 2015, a 232-for-213 split on September 28, 2017, a 737-for-659 split on December 10, 2019, a 971-for-887 split on May 20, 2020, a 236-for-231 split on October 7, 2021, a 3-for-2 split on December 3, 2021, and a 1-for-5 reverse split on July 15, 2026.
GeneOne Life Science, Inc. has split its stock 13 times. This history records 13 splits between February 6, 2006 and July 15, 2026.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In GeneOne Life Science, Inc.'s 1-for-5 reverse split on July 15, 2026, every 5 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
GeneOne Life Science, Inc. has not announced a new split in our records. Its most recent split was on July 15, 2026, less than a year ago. Companies announce splits in advance, and any new KRX:011000 split will appear on this page.
Already premium?